Skip to content

Advertisement

International Journal of Phytomedicine and Phytotherapy

Clinical Phytoscience Cover Image
  • Original contribution
  • Open Access

Phytochemical and pharmacological evaluation of methanolic extract of Lathyrus sativus L. seeds

Clinical PhytoscienceInternational Journal of Phytomedicine and Phytotherapy20184:20

https://doi.org/10.1186/s40816-018-0081-z

  • Received: 19 March 2018
  • Accepted: 5 July 2018
  • Published:

Abstract

Background

Lathyrus sativus L. (Fabaceae) has long been used as a traditional medicine for the treatment of several ailments such as Scabies, eczema, and allergy. The aim of the study was to evaluate the phytochemical nature with Central Nervous System (CNS) depressant, analgesic, antipyretic activities of the methanolic plant extract of Lathyrus sativus L. seeds in different experimental models.

Methods

Preliminary phytochemical screening and proximate analysis was carried out using different standard methods. CNS depressant activity was evaluated observing the effects of plant extract on Swiss albino mice using open field and hole-cross method. Acetic acid induced writhing and formalin induced paw licking methods were used for the appraisal of analgesic activity while 2,4-dinitrophenol (DNP) induced pyrexia model was used to investigate the antipyretic activity. The data were analyzed by one way ANOVA followed by Dunnett’s test using SPSS (version 20).

Results

The phytochemical analysis revealed the presence of wide range of phytoconstituents in the plant extract. Our investigation demonstrated that the methanolic plant extract significantly (p < 0.001) decreased the locomotor activity of mice in open field and hole-cross method at both the tested doses (200 and 300 mg/kg) which were comparable to the standard drug diazepam (1 mg/kg). The plant extracts significantly (p < 0.001) inhibited the writhing induced by acetic acid in mice to 87.09% and 80.65% (200 and 300 mg/kg respectively) compared to the standard indomethacin (70.97%). The extracts (200 and 300 mg/kg respectively) also significantly (p < 0.001) reduced the writhing to 43.39%, 64.15% in early and 46.15%, 97.44% in late phase of formalin-induced licking and biting. In 2,4-DNP induced pyrexia the extracts exhibited protection at 200 and 400 mg/kg, similar to standard drug aspirin at 150 mg/kg.

Conclusion

The results demonstrated that the plant extract has potential CNS depressant, analgesic and antipyretic activity.

Keywords

  • CNS depressant
  • Analgesic
  • Antipyretic
  • Proximate analysis
  • Lathyrus sativus L

Background

Several herbal plants have been listed in the ancient literatures for their different medicinal values and their formulation has been found to be effective for the treatment of various diseases [1]. Medicinal plants have provided us lots of bioactive natural compounds like alkaloids, carbohydrates, glycosides, saponins, flavonoids, phenolic compounds, steroids, tannins, gum, amino acids and volatile oils having a wide range of therapeutic and pharmacological potentials which are being used as raw materials for new drug discovery and development for different ailment [2, 3].

Depression of central nervous system (CNS) can be considered as a major affective brain disorder which is very prevalent now-a-days as about 5% of the general population is found to be suffering from it [4]. For the treatment of this disorder several antipsychotic drugs are available in the local medicine stores. But these drugs are reported to be hazardous to human health as they exhibit side effects like damage of autonomic, endocrine, haematopoietic systems, neurological impairment and allergic reactions [5]. Analgesics can be described as those substances which reduces the sensation of pain by alleviating pain threshold to external stimuli [6]. Contemporary analgesics like opiates and non-steroidal anti-inflammatory medications might not continually be appropriate for all patients, significantly for those with chronic pain, because of the limitations of efficacy, facet effects and intolerability. Pyrexia or fever occurs as a result of secondary implication of inflammation while enhanced production of prostaglandins is the key factor for the induction of pain, inflammation and fever [7]. Thus, most anti-inflammatory agents are also expected to possess analgesic and antipyretic activities as they inhibit or prevent excess production of prostaglandins [8]. Based on the above adverse effects of various commercial drugs there is a high demand for these arches of new drugs with lesser or no side effects. Therefore, researchers are focusing towards traditional complementary and alternative medicines to discover new drugs for the treatment of psychiatric disorders, alleviating pain and fever [911].

Lathyrus sativus L. (grass pea), belonging to Fabaceae family and locally known as “Khesari” in Bangladesh, is widely cultivated for human consumption and livestock feed in Asia and East Africa [12]. The seeds of L. sativus L. contain 28 to 32% of proteins and essential amino acids [13]. Oil extracted from the seeds of L. sativus L. are used locally as homeopathic medicine [14]. It is also used as traditional medicine in Bangladesh to cure Scabies, eczema, and allergy [15]. It was reported by several studies that the seeds of L. sativus L. possess antioxidant [16] and hypoglycemic activities [17] yet no research has been conducted regarding CNS depressant, analgesic and antipyretic activities of the plant extract. Therefore, in pursuit of searching plants possessing significant medicinal and pharmacological activities in Bangladesh and for finding out new sources of CNS depressor, analgesics and anti-inflammatory agents, here we have analyzed the crude methanolic extract of L. sativus L. seeds for its CNS depressant, analgesic and antipyretic activities and reported the results in our preliminary investigation.

Methods

Drugs and chemicals

All the chemicals used in this study were of analytical grade, and purchased from Sigma Chemical Co. (St. Louis, MO, USA), and Merck (Darmstadt, Germany). Diazepam (Incepta Pharmaceuticals Ltd.), Indomethacin (Opsonin Pharma Ltd.), Aspirin (Square Pharmaceuticals Ltd.) was used for conducting the tests.

Collection and extraction of plant material

The L. sativus L. seeds were collected from the Noakhali region, Bangladesh. The plant samples were identified by a taxonomist and a taxonomical sample specimen (DACB: 36575) was preserved in the National Herbarium of Bangladesh for future reference. The plant seeds were grounded into powder and 500 g of the sample was soaked in 99% methanol. The mixture was then filtrated and the extraction was concentrated using a rotary evaporator (RE200, Bibby Sterling, Ltd., UK) under reduced pressure at 4 rpm and 65 °C temperature. The gummy concentrate obtained was designated as crude methanolic extract. The crude methanolic extract was further freeze dried and preserved at + 4 °C for further analysis.

Test animals

Healthy Swiss albino mice, six weeks of age and weighing about 25–30 g, of both sexes were obtained from the central animal house of the Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh. The mice were housed five per cage and acclimatized in standard laboratory conditions (room temperature 24 ± 2 °C, relative humidity 55–60%, and 12 h light and dark cycles) for 7 days and were fed formulated rodent food and water prior to the research work. The study was conducted following all the rules governing the use of laboratory animals. The experimental protocol was approved by the Animal Ethics Committee of Noakhali Science and Technology University, Bangladesh.

Proximate analysis and phytochemical screening

The parameters determined for proximate analyses include moisture, ash content, crude protein and fat. The analysis was carried out using the modified method described by [18] based on method of Association of Official Analytical Chemists (AOAC, 1990). The preliminary phytochemical evaluation of the plant extract for alkaloids, carbohydrates, reducing sugar, cardiac glycosides, flavonoids, saponins, phytosterols, terpenes, phenols, proteins and amino acids, tannins and steroids were determined by using the standard procedures [1921].

Experimental design

The experimental animals were divided into control, standard and two test groups containing five mice each. For all test, Group-1 served as controls, Group-2 for standard and Group-3, Group-4 received experimental plant extract. Group 1 received the vehicle 1% Tween 80 in water (at the dose of 10 ml/kg body weight), group 2 received various standard drugs like Diazepam, Indomethacin, Aspirin at different doses [2224], and group 3 and 4 received 200–400 mg/kg dose of plant extract on the basis of toxicity study of the plant extract.

CNS depressant activity test

Open field test

This experiment was carried out in accordance with a modified method of Adebesin et al. [25].. The mice in the control group received the vehicle 1% Tween 80 in water (at the dose of 10 ml/kg body weight) while the test groups received the crude methanolic extract of L. sativus L. seeds (at the doses of 200 and 300 mg/kg body weight respectively) and standard group received diazepam at the dose of 10 mg/kg body weight (b.w.) orally. The animals were placed on the floor of an open field (100 cm × 100 cm × 40 cm h) divided into a series of squares with alternative color (black and white). The number of squares visited by each animal was counted for 3 min duration started at 0, 30, 60, 90 and 120 min after the administration of test drugs.

Hole-cross test

The method described by Hussain et al. was followed to conduct this test using a cage (30 cm × 20 cm × 14 cm) with a steel partition fixed in the middle [26]. A hole of 3 cm diameter was made at a height of 7.5 cm in the middle of the cage. The mice were divided into control (received vehicle 1% Tween 80 in water at 10 mL/kg body weight), standard (diazepam at a dose of 1 mg/kg body weight) and two test groups (received methanolic extract of seeds of L. sativus L. at the doses of 200 and 300 mg/kg body weight respectively) each having five mice. The number of passage of a mouse from one chamber to another through the hole was recorded for a period of 3 min at the 0, 30, 60, 90 and 120 min of the oral administration of test drugs.

In vivo analgesic activity test

Acetic acid induced writhing test

To evaluate the analgesic activity of the plant extract acetic acid writhing model in mice was conducted accordingly the procedure described by Koster et al. [27]. The test samples (methanolic extract of L. sativus L., 200 and 400 mg/kg body weight respectively), standard (indomethacin, 10 mg/kg body weight per orally) and control (1% Tween 80 in distilled water at the dose of 10 ml/kg body weight) were given and after 30 min 0.7% acetic acid was injected intra-peritoneally (i.p.). The writhing (constriction of abdomen, turning of trunk and extension of hind legs) was observed randomly after 15 min of interval and its frequency was counted for up to 25 min in each group of animals. The percent inhibition (% analgesic activity) was calculated by:
$$ \%\mathrm{Inhibition}=\left[\left(\mathrm{A}-\mathrm{B}\right)/\mathrm{A}\right]\times 100 $$

Where, A = Average number of writhing of the control group; B = Average number of writhing of the test or standard groups.

Formalin induced writhing test

This test was performed according to the procedure described by Viana et al. [28]. The experimental animals were separated in four groups each having 5 mice and received 1% Tween 80 in water at 10 ml/kg body weight dose per orally (p.o.) (control group), indomethacin at 10 mg/kg body weight subcutaneously (s.c.) (standard) and methanolic extract of L. sativus L. seeds at the dose of 200 and 400 mg/kg body weight p.o. (test groups). At 30 min interval the test animals were injected 50 μL of freshly prepared 0.6% solution of formalin subcutaneously, under the plantar surface of the left hind paw of each mouse. The mice were placed individually in an observation chamber and monitored for one hour. The time (in second) spent in licking and biting responses of the injected paw was taken as an indicator of pain response. Anti-nociceptive effect was determined in two phases. The early phase (Neurogenic phase) was recorded during the first 5 min, while the late phase (Inflammatory phase) was recorded during the last15–20 min after formalin injection.

Antipyretic activity test

2,4-Dinitrophenol (DNP) induced pyrexia

Adult albino mice of both sexes fasted for 24 h but allowed water ad libitum were used for the experiment. They were randomized into groups of five mice each. DNP (10 mg/kg, i.p.) was administered to the mice after obtaining the basal rectal temperatures. Hyperthermia developed within 30 min of DNP administration. Different doses of extract (200 and 400 mg/kg body weight i.p.), aspirin (150 mg/kg), and distilled water (10 ml/kg, p.o.) were administered to the treatment and control groups of animals. The rectal temperature of each animal was recorded by inserting a thermometer 2 cm into the rectum at 1, 2, 3 and 4 h after administration of the test drugs [29].

Statistical analysis

One way ANOVA with Dunnett’s post Hoc test for this experiment was carried out with SPSS 18.0 for Windows® software and the results obtained were compared with the control group. Differences between groups were considered significant at a level of p < 0.001, p < 0.01 and p < 0.05.

Results

Proximate analysis

Results of proximate analysis of dried seeds of L. sativus L. are demonstrated in Table 1. The results revealed that the plant extract has low moisture content (10.77%) and a high ash value (6.68%). It also contains moderate concentration of protein (4.27%) and low concentration of fat (1.11%).
Table 1

Proximate composition of dried L. sativus L. seeds

Proximate Analysis

Value (%)

Moisture Content

10.77

Total Ash Value

6.68

Proteins

4.27

Fat

1.11

Phytochemical screening

Table 2 reveals the quantitative phytochemical analysis of L. sativus L. seeds. The preliminary phytochemical evaluation of the plant extract confirmed the presence of alkaloids, carbohydrates, reducing sugar, flavonoids, terpenes, phenols, proteins and amino acids, and tannins.
Table 2

Phytochemical compositions of methanolic extract of L. sativus L. seeds

Phytochemical groups

Methanolic extract

Alkaloids

+

Carbohydrates

+

Reducing Sugar

+

Cardiac Glycosides

Flavonoids

+

Saponins

Phytosterols

Terpenes

+

Phenols

+

Proteins and Amino acids

+

Tannins

+

Steroids

(+) = Present of Phytochemicals and (−) = Absence of Phytochemicals

CNS depressant activity

Open field test

After statistical analysis of the experimental data (Dunnett’s test), it was observed that in open field test, the number of squares traveled by the mice was suppressed significantly in the test group throughout the study period (Table 3). The CNS depressant activity observed for the extract was dose dependent and a noticeable result was found at 120 min of test sample administration. Test animals showed significant (p < 0.001) decrease in number of movement at the dosages of 300 mg/kg (2.67 ± 0.33) and 200 mg/kg (9.33 ± 0.33), as compared to 34.67 ± 2.60 for the control group and 24.00 ± 1.53 for the standard group after 120 min of administration of the extract.
Table 3

Effect of methanolic extract of the L. sativus L. seeds on open field test in mice

Group

Number of Movements(Mean ± SEM)

0 min

30 min

60 min

90 min

120 min

Group-I

57.50 ± 2.50

50.50 ± 2.50

46.67 ± 1.76

45.33 ± 5.33

34.67 ± 2.60

Group-II

45.00 ± 2.00

33.00 ± 2.00*

31.33 ± 2.03**

15.33 ± 0.88**

24.00 ± 1.53**

Group-III

38.50 ± 1.50**

32.50 ± 2.50*

32.00 ± 2.00**

23.33 ± 1.45*

9.33 ± 0.33***

Group-IV

36.50 ± 0.50

29.50 ± 0.50*

20.67 ± 3.04**

4.33 ± 0.33**

2.67 ± 0.33***

Values are represented as mean ± SEM, (n = 5). Group I (control) animals received vehicle (1% Tween 80 in water), Group II (standard) received diazepam 1 mg/kg body weight, Group III and Group IV were treated with 200 and 300 mg/kg body weight (p.o.) of the methanolic extract of L. sativus L. seeds, respectively. ***indicates P < 0.001, **indicates P < 0.01 and *indicates P < 0.05; one-way ANOVA followed by Dunnett’s test as compared to control

Hole-cross test

Results of the hole-cross test of L. sativus L. seeds are shown in Table 4. The locomotors activity reducing effect was manifested at the 2nd observation (30 min) period and was sustained up to the 5th observation period (120 min) for the plant extract. The extract diminished the movement of the tested animals in a dose dependent manner which was comparable with standard diazepam. After 120 min of administration the extract, at the dose of 200 and 300 mg/kg, showed significant (p < 0.001) depressant activity by reducing the locomotion of the mice to 2.50 ± 0.64 (p < 0.001) and 1.25 ± 0.25 (p < 0.001) respectively. In comparison the standard drug diazepam reduced the movement of the tested animal to 2.50 ± 0.29 (p < 0.001) at the dose of 1 mg/kg.
Table 4

Effect of methanolic extract of the L. sativus L. seeds on hole cross test in mice

Group

Number of Movements (Mean ± SEM)

0 min

30 min

60 min

90 min

120 min

Group-I

11.75 ± 1.11

27.00 ± 2.45

19.50 ± 2.22

18.50 ± 1.19

20.00 ± 2.39

Group-II

6.50 ± 1.32*

11.00 ± 1.58**

5.25 ± 1.37**

9.00 ± 0.58***

2.50 ± 0.29***

Group-III

2.25 ± 0.48***

9.50 ± 1.08**

6.25 ± 1.03**

4.00 ± 0.41***

2.50 ± 0.64***

Group-IV

4.00 ± 0.91**

6.50 ± 0.87***

4.00 ± 0.71***

2.25 ± 0.29***

1.25 ± 0.25***

Values are represented as mean ± SEM, (n = 5). Group I (control) animals received vehicle (1% Tween 80 in water), Group II (standard) received diazepam 1 mg/kg body weight, Group III and Group IV were treated with 200 and 300 mg/kg body weight (p.o.) of the methanolic extract of L. sativus L. seeds, respectively. ***indicates P < 0.001, **indicates P < 0.01 and *indicates P < 0.05; one-way ANOVA followed by Dunnett’s test as compared to control

Analgesic activity

Acetic acid induced writhing method

The results showed that the pain relief was achieved in a significant (P < 0.01, P < 0.001) dose dependent manner, at all test doses (200 and 400 mg/kg body weight) as shown in figs. 1 and 2 ensured by Dunnett’s test. Maximum writhing inhibition (87.09%) was observed at 400 mg/kg dose of methanolic extract of L. sativus L. seeds while at 300 mg/kg dose it exhibited 80.65% inhibition. The inhibitory effect of indomethacin (10 mg/kg body weight) was lower (70.97%) than that of the highest dose of the plant extract.
Fig. 1
Fig. 1

Effect of L. sativus L. seeds on acetic acid induced writhing in mice. Results are given as mean ± SEM of five animals in each group. ***indicates P < 0.001, **indicates P < 0.01 when compared to control. One-way ANOVA followed by Dunnett’s test as compared to control. MLSS = Methanolic extract of L. sativus L. seeds

Fig. 2
Fig. 2

Percentage of inhibition of abdominal contractions in acetic acid induced writhing method by L. sativus L. seeds and standard indomethacin. MLSS = Methanolic extract of L. sativus L. seeds

Formalin induced paw licking method

The results of the antinociceptive effects of L. sativus L. seeds on formalin-induced paw pain response in mice are presented in Table 5. It can be seen that the highest dose (400 mg/kg b.w.) caused a significant (p < 0.001) inhibitory effect, once again in a dose dependent manner, on both phases of formalin induced pain as compared to control. The percentage of inhibition was 43.39 and 46.15% for the dose of 200 mg/kg; and 64.15 and 97.44% for 450 mg/kg b.w. in the first and second phase respectively. This potency was comparable to that of indomethacin (10 mg/kg b.w.) which produced an inhibition of 54.72% during the first phase and 71.79% during the second phase of the formalin-induced pain in mice.
Table 5

Effect of methanolic extract of the L. sativus L. seeds on formalin induced writhing in mice

Groups

Licking number (Mean ± SEM)

% Inhibition

Early phase (0–5 min)

Late phase (10–15 min)

Early phase (0–5 min)

Late phase (10–15 min)

Group-I

13.25 ± 0.63

9.75 ± 0.85

Group-II

6.00 ± 0.41

2.75 ± 0.25

54.72

71.79

Group-III

7.50 ± 0.65**

5.25 ± 0.63**

43.39

46.15

Group-IV

4.75 ± 0.48**

0.25 ± 0.25***

64.15

97.44

Values are expressed as mean ± SEM (n = 5). Group I (control) animals received vehicle (1% Tween 80 in water), Group II (standard) received indomethacin 10 mg/kg body weight, Group III and Group IV were treated with 200 and 400 mg/kg body weight (p.o.) of the methanolic extract of L. sativus L. seeds, respectively. ***indicates P < 0.001, and **indicates P < 0.01; one-way ANOVA followed by Dunnett’s t-test as compared to control. MLSS = Methanolic extract of L. sativus L. seeds

Antipyretic activity

2, 4-Dinitrophenol (DNP) induced pyrexia test

From the results (Table 6), it was observed that, experimental mice showed a marked increase in rectal temperature, 18th h after DNP injection. The extract (200 and 400 mg/kg) significantly (p < 0.05–0.01) reduced the rectal temperature of the animals in the second, third and fourth hour after administration, reaching the peak of antipyretic effect with the highest dose (400 mg/kg) in the 4th h (35.26 ± 0.52 °C, p < 0.001), in relation to control (36.95 ± 0.49 °C). Standard drug (aspiring) treatment (150 mg/kg body weight) caused significant (p < 0.05) antipyretic effect at all time periods, reaching the peak in the 4th h (35.00 ± 0.49 °C) in comparison to control.
Table 6

Effect of methanol extract of L. sativus L. seeds on 2, 4-Dinitrophenol (DNP) induced pyrexia in mice

Treatment

Temperature in °C

Initial

Pyretic

1 h

2 h

3 h

4 h

Group-I

36.23 ± 0.69

37.23 ± 0.55

37.22 ± 0.54

37.01 ± 0.5

37.01 ± 0.50

36.95 ± 0.49

Group-II

34.95 ± 0.28

36.09 ± 0.22

35.79 ± 0.30*

35.24 ± 0.29*

35.08 ± 0.27*

35.00 ± 0.28*

Group-III

35.97 ± 0.73

36.93 ± 0.78

36.79 ± 0.76

36.41 ± 0.82

36.29 ± 0.77

36.22 ± 0.82

Group-IV

34.86 ± 0.13

36.09 ± 0.19

35.87 ± 0.13

35.25 ± 0.16*

35.08 ± 0.14*

34.87 ± 0.13**

Values are expressed as mean ± SEM (n = 5). Group I (control) animals received distilled water (10 ml/kg), Group II (standard) received aspirin 150 mg/kg body weight, Group III and Group IV were treated with 200 and 400 mg/kg body weight (p.o.) of the methanolic extract of L. sativus L. seeds, respectively. ***indicates P < 0.001, and **indicates P < 0.01; one-way ANOVA followed by Dunnett’s t-test as compared to control. MLSS = Methanolic extract of L. sativus L. seeds

Discussion

In our research work we tried to explicate diverse pharmacological potency of the methanolic extract of L. sativus L. in mice along with the proximate and phytochemical analysis. The proximate analysis of the plant extract was carried out to evaluate its moisture, total ash, protein and fat content. It is a very important technique for the product development and quality control or regulatory purposes in the food industry and also for the purity and quality test of crude drugs in pharmaceutical industry [30]. Our study results demonstrated that the methanolic plant extract had a low moisture content which indicates that the preservation period of the extract will be high as it is evident that moisture content in the range of 5–15% are good for formulating and also hinder the microbial growth [31]. The moderate amount of ash content in the plant extract suggests that it is comparatively rich in different types of minerals. Ash content estimation is necessary because the inorganic elements or minerals may be the cause of a pharmacological impact [32]. Proximate analysis also revealed that the plant possess moderate amount of protein and lower amount of fat. Protein plays a major role in various body functions like body development, fluid balance, hormone and enzyme formation and also sustaining strong immune function. While low content of fat (below the range 8.3–27.0%) is reported to be poor sources of lipids and thus increase in the consumption of the vegetables would naturally lower fat intake [32].

The secondary metabolites (phytochemicals) of a plant extract are responsible for the pharmacological actions of that plant or plant parts and thus estimation of those bioactive compounds may be used to treat chronic as well as infectious diseases [30]. Our study was an evidential approach to ascertain the mentioned pharmacological functions of L. sativus L. seeds and found to have the presence of alkaloids, carbohydrates, reducing sugar, flavonoids, terpenes, phenols, proteins and amino acids, and tannins in the plant extract. Several studies reported that alkaloids possess various pharmacological activities like antihypertensive, antiarrhythmic, antimalarial and anticancer activity [33]. Pure alkaloids and their synthetic compounds have also been reported to be used as analgesic, antispasmodic and antibacterial agents [32]. Carbohydrates and reducing sugar are essential nutrient for the body as they produce energy required and supplies energy to brain, muscle and blood [34]. Terpenes possess medicinal properties such as anticarcinogenic, antimalarial, antiulcer, antimicrobial and diuretic activity [32]. Phenols, flavonoids and tannins are the major groups responsible for antioxidant activity [31]. Previous studies showed that saponins demonstrated antibacterial, antiinflammatory, anticancer, and antidiabetic activities [35].

Two different neuropharmacological models, namely open field and hole-cross test, were used to study the CNS depressant activity of L. sativus L. seed extract. The results of the study provided evidence that the plant extract significantly (p < 0.001) induced sedative-hyponotic activity in test animals confirming their CNS depressant activity. Gamma-aminobutyric acid (GABA) is evidenced to be the major inhibitory neurotransmitter of CNS and several anxiolytic, muscle relaxant and sedative-hypnotic drugs exhibit their action via GABA [36]. Thus it can be pretended that the methanolic seed extract may act by commencing the GABAergic inhibition of the CNS through membrane hyperpolarization that lead to a reduction in the firing rate of critical neurons in the brain or the extract may simply activate the GABA receptors directly [37]. Again, research has shown that plants containing alkaloids, flavonoids and tannins are useful for the treatment of many CNS disorders as they reduce the locomotor activity of the CNS [38] which led to the postulation that these compounds may act as benzodiazepine like molecules [39]. Earlier investigation of the phytoconstituents of L. sativus L. proved the presence of these phytochemicals [40]. Thus it may be predicted that these compounds may also be responsible for the CNS depressant activity of the plant extracts though the key compound for producing such effect is yet to be discovered.

Among various available test to evaluate the analgesic activity of different compounds, Acetic acid-induced writhing is a well recommended protocol in evaluating the peripheral analgesic property of medicinal agents due to its sensitivity and response to the compounds at a dose which is not effective in other methods [41]. In our study, assessment of analgesic activity using the acetic acid induced writhing test revealed that oral administration of L. sativus L. seeds produced a statistically significant inhibition of writhes compared to the control. This is an indication of the peripheral analgesic activity of the active principle(s) of the plant extract, since any agent that lowers the writhing number, demonstrates analgesia by inhibiting prostaglandin synthesis which is a peripheral mechanism of pain inhibition [42]. Here the pain induction is caused by liberating endogenous substances as well as some other pain mediators such as arachidonic acid via cyclooxygenase, and prostaglandin biosynthesis (specifically lipoxygenase, PGE2 and PGF2α) [43]. These products enhance capillary permeability affecting local pain receptor that results in inflammation and pain [41].

In order to obtain more specific evidence on the possible mechanism of analgesic activity of L. sativus L. seeds, the effect of different doses of the plant extract on formalin test was examined. This test model is considered as a method of persistent pain produced by the intra-plantar injection of formalin that induces a biphasic nociceptive behavior. The early phase (0–5 min) is characterized by neurogenic pain caused by C-fibre activation due to the stimulation of peripheral nociceptors caused by formalin [44]. A second burst of licking behavior occurs after 15 to 30 min and seems to be characterized by the inflammatory response elicited by formalin which is triggered by a combination of stimuli, including inflammation of the peripheral tissues and mechanisms of central sensitization [45, 46]. Again it is assumed that manifestation in the late phase is due to inflammation causing a release of serotonin, histamine, bradykinin and prostaglandins, which at least to some degree can cause the sensitization of the central nociceptive neurons [47]. It is reported that substance P is involved in the first phase whereas histamine, serotonin, prostaglandins and bradykinin are responsible for the second phase of inflammation [45]. In our research, the extract demonstrated antinociceptive activity in blocking both phases of the formalin response although the effect of the extract was more pronounced in the late phase of test. As oral pretreatment with L. sativus L. inhibited the first (neurogenic pain) and second (inflammatory nociception) phases of formalin-induced licking in mice therefore it may be postulated that the plant extract may possess both peripheral and central effect.

On antipyretic activity the plant extract significantly inhibited DNP induced pyrexia at both the concentrations. In generally, non-steroidal anti-inflammatory drugs (NSAIDs) exhibit their antipyretic effect through inhibiting the production of prostaglandins specifically prostaglandin E2 (PGE2) in the hypothalamus [48]. Thus it may be assumed that the plant extract may have functioned as a cyclooxygenase-2 (COX-2) antagonist through the inhibition of PGE2 production in the hypothalamus or by the enhancement of body’s own antipyretic substances such as vasopressin and arginine production [29, 48]. Furthermore, the extract could have also been mediated its hypothermic activity by vasodilatation of superficial blood vessels resulting in increased dissipation of heat following resetting of hypothalamic temperature control center [49]. However, all these actions may be due to presence of certain phytochemical compounds in this plant as several studies have reported that steroids, tannins, triterpenoids, flavonoid and coumarin glycosides are responsible for antipyretic activity [50]. Our investigated plant also contains tannis, terpenoids and flavonoid which may have attributed to its potent antipyretic activity.

Conclusion

On the basis of the findings of the present study it can be easily stated that the methanolic extract of Lathyrus sativus L. seeds possesses remarkable pharmacological potentialities. The results of our research work also supplicate its traditional uses for various medical purposes. Therefore, the experimental evidence obtained in the laboratory test model could justify for the traditional use of this plant as a CNS depressant, analgesic, and antipyretic agent.

Abbreviations

AOAC: 

Association of Official Analytical Chemists

b.w.: 

Body Weight

CNS: 

Central Nervous System

COX-2: 

Cyclooxygenase-2

DNP: 

Dinitrophenol

GABA: 

Gamma-aminobutyric acid

i.p.: 

Intra-Peritoneally

NSAID: 

Non-Steroidal Anti-Inflammatory Drug

p.o.: 

Per Orally

PGE2: 

Prostaglandin E2

s.o.: 

Subcutaneously

Declarations

Acknowledgements

The authors are also thankful to all the teachers and staffs of the Department of Pharmacy, Noakhali Science and Technology University for their cordial co-operation by providing laboratory support to carry out the research work.

Funding

This research work was carried out by the author in the partial fulfillment of the requirements for the degree of Bachelor of Science (Hons) in Applied Chemistry and Chemical Engineering. Authors did not receive any funding for conducting the research work.

Availability of data and materials

The datasets analyzed during the current study are available from the corresponding author on request.

Authors’ contributions

MAW and KB carried out the collection of plant, extraction process and conducted the research work. AD wrote the manuscript. SB and AD* carried out conception and design of the study, statistical analysis and interpretation of data. SB and SRD helped in the plant collection procedure, revised the manuscript and guided to improve the quality of final manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by ethical research committee of Noakhali Science and Technology University, Bangladesh.

Consent for publication

Not applicable.

Competing interests

The author reports no conflict of interests in this work.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Applied Chemistry and Chemical Engineering, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh
(2)
Department of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh
(3)
Department of Environmental Science and Disaster Management, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh

References

  1. Senthilkumar R, Ahmedjohn S, Archunan G, Manoharan N. Antioxidant activity of Wedelia chinensis in alloxan induced diabetic rats. Pharmacologyonline. 2008;2:640–51.Google Scholar
  2. Hasan MM, Hossain A, Shamim A, Rahman MM. Phytochemical and pharmacological evaluation of ethanolic extract of Lepisanthes rubiginosa L leaves. BMC Complement Altern Med. 2017;17(1):496.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Akinmoladun AC, Ibukun EO, Afor E, Obuotor EM, Farombi EO. Phytochemical constituent and antioxidant activity of extract from the leaves of Ocimum gratissimum. Sci Res Essays. 2007;2(5):163–6.Google Scholar
  4. Hoskeri JH, Venkatarangaiah K, Hanumanthappa SK, Vootla SK, Gadwala M. CNS depressant activity of extracts from Flaveria trinervia spring C. Mohr Phytopharmacol. 2011;1:101–8.Google Scholar
  5. Zhang ZJ. Therapeutic effect of herbal extract and constituents in animal models of psychiatric disorders. Life Sci. 2004;75:1659–99.View ArticlePubMedGoogle Scholar
  6. Kumar JP, Shankar NB. Analgesic activity of Mollugo pentaphylla Linn by tail immersion method. Asian J Pharm Clin Res. 2009;2:61–3.Google Scholar
  7. Khan MA, Baki A, Al-Bari MA, Hasan S, Mosaddik MA, Rahman MM, et al. Antipyretic activity of roots of Laportea crenulata gaud in rabbit. Res J Med Med Sci. 2007;2(2):58–61.Google Scholar
  8. Dewanjee S, Maiti A, Sahu R, Dua TK, Mandal SC. Study of anti-inflammatory and antinociceptive activity of hydroalcoholic extract of Schima wallichii bark. Pharm Biol. 2009;47(5):402–7.View ArticleGoogle Scholar
  9. Selvi PT, Kumar MS, Yaswanth T, Adiyaman E, Anusha PT. Central nervous system depressant activity of aqueous extract of leaves of Azadirachta indica Linn in mice. Asian J Pharm Res. 2012;2:97–9.Google Scholar
  10. Sulaiman MR, Zakaria ZA, Chiong HS, Lai SK, Israf DA, Tg TM, et al. Antinociceptive and anti-inflammatory effects of Stachytarpheta jamaicensis (L.) Vahl (Verbenaceae) in experimental animal models. Med Princ Pract. 2009;18:272–9.View ArticlePubMedGoogle Scholar
  11. Ibrahim B, Sowemimo A, van Rooyen A, Van de Venter M. Antiinflammatory, analgesic and antioxidant activities of Cyathula prostrata (Linn.) Blume (Amaranthaceae). J Ethnopharmacol. 2012;141(1):282–9.View ArticlePubMedGoogle Scholar
  12. Ramakrishna V, Rajasekhar S, Reddy LS. Identification and purification of metalloprotease from dry grass pea (Lathyrus sativus L.) seeds. Appl Biochem Biotechnol. 2010;160(1):63.View ArticlePubMedGoogle Scholar
  13. Urga K, Fufa H, Biratu E, Husain A. Evaluation of Lathyrus sativus cultivated in Ethiopia for proximate composition, minerals, β-ODAP and anti-nutritional components. African J food, Agricul Nutr. Dev. 2005;5(1):1–15.Google Scholar
  14. Duke J. Handbook of legumes of world economic importance. Springer Science & Business Media. 2012;Google Scholar
  15. Ahsan S, Jahan R, Ahmad I, Chowdhury H, Rahmatullah M. A survey of medicinal plants used by Kavirajes of Barisal town in Barisal district. Bangladesh American-Eurasian J Sust Agric. 2010;4(2):237–46.Google Scholar
  16. Sarmento A, Barros L, Fernandes Â, Carvalho AM, Ferreira IC. Valorization of traditional foods: nutritional and bioactive properties of Cicer arietinum L. and Lathyrus sativus L. pulses. J Sci Food Agric. 2015;95(1):179–85.View ArticlePubMedGoogle Scholar
  17. Sultana A, Rahmatullah M. Antihyperglycemic activity of methanolic extract of non-boiled and boiled Lathyrus sativus L. seeds. J Chem Pharm Res. 2016;8(8):874–6.Google Scholar
  18. Oluduro AO. Evaluation of antimicrobial properties and nutritional potentials of Moringa oleifera lam. Leaf in South_Western Nigeria, Malaysian. J Microbiol. 2012;2(8):59–67.Google Scholar
  19. Harborne JB. Phytochemical methods. A guide to modern techniques of plant analysis, vol. 13. London, New York: Chapman and Hall Ltd; 1973. p. 49–188.Google Scholar
  20. Roopashree TS, Dang R, Rani SRH, Narendra C. Antibacterial activity of anti-psoriatic herbs: Cassiatora, Momordica charantia and Calendula officinalis. Int J Appl Res Nat Prod. 2005;1(3):20–8.Google Scholar
  21. Sofowora AE. Recent trends in research into African medicinal plants. J Ethnopharmacol. 1993;389:209–14.Google Scholar
  22. Nahar L, Zahan R, Morshed MTI, Haque A, Alamand Z, Mosaddik A. Antioxidant, analgesic and CNS depressant effects of Synedrella Nodiflora. PHOG J. 2012;4(31):29–36.Google Scholar
  23. Murugesan T, Ghosh L, Das J, Pal M, Saha BP. CNS activity of Jussiaea suffruticosa Linn. Extract in rats and mice. Pharm Pharmacol Commun. 1999;5:663–6.View ArticleGoogle Scholar
  24. Essien AD, Essiet GA, Akuodor GC, Akpan JL, Chilaka KC, Bassey AL, Ezeokpo BC, Nwobodo NN. Pharmacological evaluation of the aqueous stem bark extract of Bombax buonopozense in the relief of pain and fever. Afr J Pharm Pharmacol. 2016;10(5):59–65.View ArticleGoogle Scholar
  25. Adebesin IF, Akindele AJ, Adeyemi OO. Evaluation of neuropharmacological effects of aqueous leaf extract of Albizia glaberrima (Leguminosae) in mice. J Ethnopharmacol. 2015;160:101–8.View ArticlePubMedGoogle Scholar
  26. Hussain J, Ur Rehman N, Hussain H, Al-Harrasi A, Ali L, Rizvi TS. Analgesic, anti-inflammatory, and CNS depressant activities of new constituents of Nepeta clarkei. Fitoterapia. 2012;83(3):593–8.View ArticlePubMedGoogle Scholar
  27. Koster R, Anderson M, DeBeer EJ. Acetic acid analgesic screening. Fed Proc. 1959;18:418–20.Google Scholar
  28. Viana GS, Do Vale TG, Rao VSN, Matos FJA. Analgesic and antiinflammatory effects of two chemotypes of Lippia alba: a comparative study. Pharm Biol. 1998;36(5):347–51.View ArticleGoogle Scholar
  29. Okokon J, Davis KA, Azare BA. Antipyretic and antimalarial activities of Solenostemon monostachyus. Pharm Biol. 2016;54(4):648–53.View ArticlePubMedGoogle Scholar
  30. Shukla A, Vats S, Shukla RK. Phytochemical screening, proximate analysis and antioxidant activity of Dracaena reflexa lam. Leaves. Indian J Pharm Sci. 2015;77(5):640.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Islam MZ, Hossain MT, Hossen F, Mukharjee SK, Sultana N, Paul SC. Evaluation of antioxidant and antibacterial activities of Crotalaria pallida stem extract. Clinical Phytosci. 2018;4(1):8.View ArticleGoogle Scholar
  32. Achi NK, Onyeabo C, Ekeleme-Egedigwe CA, Onyeanula JC. Phytochemical, proximate analysis, vitamin and mineral composition of aqueous extract of Ficus capensis leaves in south eastern Nigeria. J Appl Pharm Sci. 2017;7(3):117–22.Google Scholar
  33. Saxena M, Saxena J, Nema R, Singh D, Gupta A. Phytochemistry of medicinal plants. J Pharmacog Phytochem. 2013;1(1):168–82.Google Scholar
  34. Ejelonu BC, Lasisi AA, Olaremu AG, Ejelonu OC. The chemical constituents of calabash (Crescentia cujete). African J Biotechnol. 2011;10(84):19631–6.View ArticleGoogle Scholar
  35. Urzúa A, Rezende MC, Mascayano C, Vásquez L. A structure-activity study of antibacterial diterpenoids. Molecules. 2008;13:882–91.View ArticlePubMedGoogle Scholar
  36. Wong CG, Bottiglieri T, Snead OC. Gaba, γ-hydroxybutyric acid, and neurological disease. Annals Neurol. 2003;54(S6):S3-12.Google Scholar
  37. Kolawole OT, Makinde JM, Olajide OA. Central nervous system depressant activity of Russelia equisetiformis. Niger J Physiol Sci. 2007;22:59–63.PubMedGoogle Scholar
  38. Hossain MS, Akter S, Das A, Sarwar MS. CNS depressant, antidiarrheal and antipyretic activities of ethanolic leaf extract of Phyllanthus acidus L. on Swiss albino mice. British J Pharm Res. 2016;10(5):1.View ArticleGoogle Scholar
  39. Verma A, Jana GK, Sen S, Chakraborty R, Sachan S, Mishra A. Pharmacological evaluation of Saraca indica leaves for central nervous system depressant activity in mice. J Pharm Sci Res. 2010;2(6):338–43.Google Scholar
  40. Campbell CG. Grass pea, Lathyrus sativus L. In: Bioversity International; 1997.Google Scholar
  41. Muhammad N, Saeed M, Khan H. Antipyretic, analgesic and anti-inflammatory activity of Viola betonicifolia whole plant. BMC Complement Altern Med. 2012;12:59.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Loganayaki N, Siddhuraju P, Manian S. Antioxidant, anti-inflammatory and anti-nociceptive effects of Ammannia baccifera L. (Lythracceae), a folklore medicinal plant. J Ethnopharmacol. 2012;140:230–3.View ArticlePubMedGoogle Scholar
  43. Khan H, Saeed M, Gilani AUH, Khan MA, Dar A, Khan I. The antinociceptive activity of Polygonatum verticillatum rhizomes in pain models. J Ethnopharmacol. 2010;127(2):521–7.View ArticlePubMedGoogle Scholar
  44. Alam MA, Subhan N, Awal MA, Alam MS, Sarder M, Nahar L, et al. Antinociceptive and anti-inflammatory properties of Ruellia tuberosa. Pharm Biol. 2009;47:209–14.View ArticleGoogle Scholar
  45. Abdala S, Dévora S, Martín-Herrera D, Pérez-Paz P. Antinociceptive and anti-inflammatory activity of Sambucus palmensis link, an endemic Canary Island species. J Ethnopharmacol. 2014;155:626–32.View ArticlePubMedGoogle Scholar
  46. Milano J, Oliveira SM, Rossato MF, Sauzem PD, Machado P, Beck P, Zanatta N, et al. Antinociceptive effect of novel trihalomethyl-substituted pyrazoline methyl esters in formalin and hot-plate tests in mice. Eur J Pharmacol. 2008;581:86–96.View ArticlePubMedGoogle Scholar
  47. Verma PR, Joharapurkar AA, Chatpalliwar VA, Asnani A. Antinociceptive activity of alcoholic extract of Hemidesmus indicus r.Br. In mice. J Ethnopharmacol. 2005;102:298–301.View ArticlePubMedGoogle Scholar
  48. Binny K, Kumar SG, Dennis T. Anti-inflammatory and antipyretic properties of the rhizome of Costus speciosus (koen.) sm. J Basic Clinical Pharm. 2010;1(3):177.Google Scholar
  49. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 6th ed. Edinburgh: Churchill Livingstone; 2007.Google Scholar
  50. Hossain E, Mandal SC, Gupta JK. Phytochemical screening and in-vivo antipyretic activity of the methanol leaf-extract of Bombax malabaricum DC (Bombacaceae). Tropical J Pharma Res. 2011;10(1)Google Scholar

Copyright

© The Author(s). 2018

Advertisement